Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
On June 6, I wrote to the secretary of Health and Human Services (HHS) to make sure that taxpayers and Medicare recipients are not forced to pay $26,500 for the new Alzheimer’s drug Leqembi – which independent experts estimated should be lowered to $8,900.
Simplified Text
Author wrote to HHS on June 6 to prevent taxpayers Medicare recipients paying $26500 for Leqembi.
Confidence Score
0.900
Claim Maker
The author
Context Type
Op-Ed
Context Details
{
    "date": "June 6",
    "drug": "Leqembi",
    "organization": "Health and Human Services (HHS)"
}
Subject Tags
UUID
9fdb2e89-95d3-4760-83f2-892e17dab236
Vector Index
✗ No vector
Created
September 12, 2025 at 12:34 AM (15 hours ago)
Last Updated
September 12, 2025 at 12:34 AM (15 hours ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.sanders.senate.gov/op-eds/the-greed-of-big-pharma-cannot-continue/
44 claims 🔥
15 hours ago
https://www.sanders.senate.gov/op-eds/the-greed-of-big-pharma-cannot-continue/

Senator Sanders criticizes exorbitant prescription drug prices in the US, highlighting the industry's lobbying power and advocating for price controls.

Pharmaceutical Industry
Healthcare Costs
Drug Pricing
Lobbying
US Politics
Medicare

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP